News

New Topical Steroid Approved for Plaque Psoriasis

Dr. Reddy's announced that Promius Pharma has received approval for Sernivo (betamethasone dipropionate) Spray 0.05% for the treatment of mild to moderate plaque psoriasis in patients aged ≥18 years.

Does Having a Respiratory Condition Lower the Risk of Glioma?

Patients with respiratory allergies, asthma, and eczema may be less likely to develop a glioma, according to a study published in the February issue of Cancer Epidemiology, Biomarkers & Prevention.

Findings Released for First Autopsy on Fatal MERS-CoV Case

The main histopathologic findings of Middle East respiratory syndrome coronavirus (MERS-CoV) infection are diffuse alveolar damage in the lungs and evidence of chronic disease in other organs, according to research published online in The American Journal of Pathology.

What Effect has Texas' Planned Parenthood Exclusion had?

Exclusion of the Planned Parenthood affiliates in Texas is associated with a reduction in the provision of contraception, according to a study published online in the New England Journal of Medicine.

Electronic Health Records Need to Offer 'Big Picture', Doctors Say

Physicians recently met in Seattle to discuss the difficulties and benefits associated with electronic health records (EHRs) in a third town hall meeting on the subject, according to a report published by the American Medical Association.

CDC Guidelines on Preventing Sexual Transmission of Zika Virus Issued

After 3 reported cases of possible sexual transmission of Zika virus, the CDC has released interim guidelines to prevent sexual transmission.

CDC Updates Interim Zika Virus Guidelines for Pregnant Women and Women of Reproductive Age

Serologic testing for Zika virus has been recommended in asymptomatic pregnant women, who have traveled to, or reside in, areas of ongoing transmission.

Daklinza Use Expanded to Cover Treatment in More HCV Patients

Bristol-Myers Squibb announced that the Food and Drug Administration (FDA) has approved Daklinza (daclatasvir) for use in combination with sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotypes 1 and 3.

Researchers Call for an Alternative Tdap Immunization Strategy for Adolescents

The Tdap booster vaccine provided moderate protection against whooping cough during the first year post-vaccination but its efficacy decreased to <9% just 4 years post-vaccination among teenagers who received a newer form of the acellular pertussis vaccine as infants and children.

FDA Announces Large Action Plan in Effort to Reverse the Opioid Epidemic

The FDA has announced a new action plan designed to reassess their approach to opioid medications.